Advertisement

Topics

Optimer Nabs $68M in Stock Sale

09:40 EST 11 Feb 2011 |

San Diego-based Optimer Pharmaceuticals (NASDAQ: OPTR) said today it has raised $67.5 million through a stock offering. The company sold 6 million new shares at $11.25 apiece. The underwriters have an option to buy another 900,000 shares over the next 30 days, which would add more money to the deal. Jefferies & Co., Baird, Canaccord [...]

Original Article: Optimer Nabs $68M in Stock Sale

NEXT ARTICLE

More From BioPortfolio on "Optimer Nabs $68M in Stock Sale"

Advertisement
Quick Search
Advertisement
Advertisement